Form 4: REGENXBIO Executive Danos Sells Shares to Cover Tax Obligations

Olivier Danos, Chief Scientific Officer of REGENXBIO Inc., sold shares to cover tax obligations arising from the vesting of restricted stock units.

Summary

• On February 1, 2025, Olivier Danos, the Chief Scientific Officer of REGENXBIO Inc., disposed of 5,452 shares of common stock to cover tax obligations.
• The shares were withheld to pay taxes upon the vesting of restricted stock units originally granted on August 1, 2024.
• The transaction was executed at a price of $8.07 per share.
• Following the transaction, Danos directly owns 226,348 shares of REGENXBIO Inc.
• The transaction was reported on April 4, 2025.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (covering tax obligations) and doesn't inherently indicate positive or negative sentiment towards the company's prospects.

Industry Context

Executive stock transactions are a normal part of corporate governance. Sales to cover tax obligations are common and don't necessarily indicate a negative outlook on the company.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

REGENXBIO, Insider Trading, Form 4, Stock Sale, Tax Obligations, Olivier Danos, RGNX, Executive Compensation, Restricted Stock Units